Ortikos, an anti-inflammatory corticosteroid, is approved as a once-daily treatment for mild to moderate active Crohn disease and for maintenance of clinical remission. Ferring Pharmaceuticals ...

Systemic corticosteroids, such as prednisolone, are linked to OSTEOPOROSIS in patients with Crohn's disease. In controlled-release (CR) capsule form, budesonide is a locally acting corticosteroid with ...

Mylan has received final approval from the FDA to launch Budesonide Capsules, 3mg (enteric-coated), the generic version of Entocort EC (AstraZeneca) capsules. This is the first generic version of this ...

The FDA granted accelerated approval for the first drug to reduce proteinuria in primary immunoglobulin A (IgA) nephropathy, the agency announced on Wednesday. The delayed released budesonide (Tarpeyo ...

Budesonide is recommended as one of the first-line drugs for treatment of eosinophilic esophagitis (EoE), a chronic immune-mediated inflammatory disease, and in a recent study researchers updated a ...

As asthma symptoms worsen, patients typically rely on short-acting β 2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma ...

As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-severe ...

* Has completed its agreement with Perrigo Company Plc for divestment of US rights to Entocort (budesonide) * Upon completion of agreement, Perrigo paid Astrazeneca $380 million to acquire rights to ...

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease 19 (COVID-19), emerged in December 2019 in Wuhan, China, and continues to spread worldwide.

Background An adolescent boy aged 17 years presented with sudden onset of visual impairment, which was rapidly diagnosed as bilateral anterior uveitis by an ophthalmologist. A systemic review noted ...